Sugimura Sho, Khanh Huynh V, Kawashima Shingo, Nakajima Yoshiki, Kinoshita Hiroyuki
Departments of Anesthesiology and Intensive Care, Hamamatsu University School of Medicine, Hamamatsu, JPN.
Departments of Anesthesiology and Intensive Care Medicine, Hamamatsu University School of Medicine, Hamamatsu, JPN.
Cureus. 2023 Sep 4;15(9):e44670. doi: 10.7759/cureus.44670. eCollection 2023 Sep.
Background Mechanistic insight into the high failure rate of TOF-Cuff® (RGB Medical Devices, Madrid, Spain) measurements on the lower leg is unclear. Aims We aimed to determine whether materials applied to pseudo-skin can reduce the impedance between a model arm and TOF-Cuff® electrodes and whether a material between TOF-Cuff® electrodes and the patient's skin surface decreases the skin-TOF-Cuff® electrode impedance within the appropriate range. Methods This was a combination of an in vitro study using non-living materials and a prospective observational clinical study. Eight patients aged > 70 years who had undergone elective surgery were eligible. One of the primary outcomes was whether water, electrocardiogram (ECG) cream, or ECG gel applied on the pseudo-skin could reduce the impedance between the model arm and the TOF-Cuff® electrodes in the in vitro study. Another was whether a material between the TOF-Cuff® electrodes and the patient's skin surface decreased the skin-TOF-Cuff® electrode impedance to an appropriate level of less than 5,000 Ω in the clinical study. Results The application of water, ECG cream, and ECG gel similarly reduced the impedance values within the electrical circuit in the in vitro study. ECG cream application between the patient's skin surface and the TOF-Cuff® electrodes decreased the skin-TOF-Cuff® electrode impedance (median (interquartile range (IQR)) Ω) from 8,600 (6,450 to 9,775) to 2,000 (1,600 to 2,600) (P = 0.012) in surgical patients. Conclusion ECG cream application between the patient's skin surface and the TOF-Cuff® electrodes decreased the skin-TOF-Cuff® electrode impedance appropriately, and thus, the application can facilitate precise TOF-Cuff® measurements in patients.
关于TOF-Cuff®(RGB医疗器械公司,西班牙马德里)测量小腿时高失败率的机制尚不清楚。目的:我们旨在确定应用于假皮肤的材料是否能降低模型手臂与TOF-Cuff®电极之间的阻抗,以及TOF-Cuff®电极与患者皮肤表面之间的材料是否能在适当范围内降低皮肤-TOF-Cuff®电极阻抗。方法:这是一项结合使用非生物材料的体外研究和前瞻性观察性临床研究。入选了8名年龄大于70岁且接受择期手术的患者。主要结果之一是在体外研究中,涂抹在假皮肤上的水、心电图(ECG)乳膏或ECG凝胶是否能降低模型手臂与TOF-Cuff®电极之间的阻抗。另一个结果是在临床研究中,TOF-Cuff®电极与患者皮肤表面之间的材料是否能将皮肤-TOF-Cuff®电极阻抗降低到适当水平,即小于5000Ω。结果:在体外研究中,涂抹水、ECG乳膏和ECG凝胶同样降低了电路中的阻抗值。在手术患者中,在患者皮肤表面与TOF-Cuff®电极之间涂抹ECG乳膏可使皮肤-TOF-Cuff®电极阻抗(中位数(四分位间距(IQR))Ω)从8600(6450至9775)降至2000(1600至2600)(P = 0.012)。结论:在患者皮肤表面与TOF-Cuff®电极之间涂抹ECG乳膏可适当降低皮肤-TOF-Cuff®电极阻抗,因此,这种涂抹有助于对患者进行精确的TOF-Cuff®测量。